Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Researchers in Oxford have begun screening participants in DPUK’s Deep and Frequent Phenotyping (DFP) study – the world’s most detailed study into early Alzheimer’s disease.

First participant arrives for screening as part of Deep and Frequent Phenotyping study
Study volunteer Gillian Brown talks to DFP trial co-ordinator Dr Tony Thayanandan

Launched last month, the DFP study is jointly funded by the MRC and NIHR, and aims to tackle the challenge of diagnosing and tracking Alzheimer’s disease in its earliest stages – often decades before symptoms start to show.

DFP will recruit 250 participants from across the UK who are over 60 and in good health, but with a family history of dementia. Volunteers will undergo a range of existing and novel tests over a year-long period, including brain scans, cognitive and memory tests, scans of brain magnetic fields, retinal imaging, blood tests, and the use of wearable technology to measure movement, gait and ongoing cognitive abilities.

This will be the most comprehensive set of assessments ever completed in this group of people. Data from the study will be made available to researchers via the secure DPUK Data Portal.

Read more (Dementias Platform UK website)